JD Health International's (HKG:6618) attributable profit for the six months ended June 30 climbed to 2.04 billion yuan from 1.56 billion yuan a year prior.
Earnings per share increased to 0.65 yuan from 0.49 yuan a year earlier, according to a Thursday filing with the Hong Kong Exchange.
The Chinese online healthcare platform's revenue rose by 4.6% to 28.3 billion yuan from 27.1 billion yuan in the year-ago period.
The company attributed the revenue growth to higher sales of pharmaceutical and healthcare products.
Price (HKD): $19.82, Change: $-0.63, Percent Change: -3.08%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments